These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
147 related items for PubMed ID: 8633568
1. Gastric premalignancy and cancer screening in high-risk patients. Yoshida S, Saito D. Am J Gastroenterol; 1996 May; 91(5):839-43. PubMed ID: 8633568 [No Abstract] [Full Text] [Related]
2. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. de Vries AC, van Grieken NC, Looman CW, Casparie MK, de Vries E, Meijer GA, Kuipers EJ. Gastroenterology; 2008 Apr; 134(4):945-52. PubMed ID: 18395075 [Abstract] [Full Text] [Related]
3. Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population. Zhang L, Blot WJ, You WC, Chang YS, Kneller RW, Jin ML, Li JY, Zhao L, Liu WD, Zhang JS, Ma JL, Samloff IM, Correa P, Blaser MJ, Xu GW, Fraumeni JF. Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):627-30. PubMed ID: 8824365 [Abstract] [Full Text] [Related]
4. The usefulness of gastric mass screening using serum pepsinogen levels compared with photofluorography. Yoshihara M, Sumii K, Haruma K, Kiyohira K, Hattori N, Tanaka S, Kajiyama G, Shigenobu T. Hiroshima J Med Sci; 1997 Jun; 46(2):81-6. PubMed ID: 9232936 [Abstract] [Full Text] [Related]
5. [Serologic screening for preneoplastic pathology and early stomach cancer]. Maev IV, Mel'nikova EV, Kashin SV, Nadezhin AS, Kriukova TV. Klin Med (Mosk); 2008 Jun; 86(11):43-8. PubMed ID: 19177794 [Abstract] [Full Text] [Related]
6. Validity of serum pepsinogen levels and quininium resin test combined for gastric cancer screening. Kim JR, Lee K, Jung WT, Lee OJ, Kim TH, Kim HJ, Lee JS, Passaro DJ. Cancer Detect Prev; 2005 Jun; 29(6):570-5. PubMed ID: 16289505 [Abstract] [Full Text] [Related]
7. Cancer precursor lesions in intact stomach Helicobacter pylori gastritis and in resected stomach gastritis. Giuliani A, Spada S, Corona M, Demoro M, Di Bari M, Ricciardulli T, Galati G, Caporale A, Tocchi A, Angelico F. J Exp Clin Cancer Res; 2003 Sep; 22(3):371-8. PubMed ID: 14582693 [Abstract] [Full Text] [Related]
8. Background submucosal cysts in early gastric cancer cases have unique clinicopathologic features suggestive of postgastritis and significant smoking association. Ichinoe M, Mikami T, Hara A, Tsuruta T, Okayasu I. Am J Clin Pathol; 2007 Nov; 128(5):746-52. PubMed ID: 17951195 [Abstract] [Full Text] [Related]
9. [Risk factors of gastric cancer in Wuwei City---an endemic region of gastric cancer]. Luo HZ, Mi DH, Jing TZ, Xu Q, Yang WS, Yang GQ, Wang SZ, Liu GH, Su CY. Ai Zheng; 2005 May; 24(5):563-6. PubMed ID: 15890098 [Abstract] [Full Text] [Related]
10. Comparison of the anatomic distribution of stomach cancer and precancerous gastric lesions. You WC, Blot WJ, Chang YS, Li JY, Jin M, Zhao YX, Kneller RW, Xie YQ, Zhang L, Xu GW. Jpn J Cancer Res; 1992 Nov; 83(11):1150-3. PubMed ID: 1483930 [Abstract] [Full Text] [Related]
11. Prevalence of precancerous lesions of the stomach in Venezuela. Muñoz N, Kato I, Peraza S, Lopez G, Carrillo E, Ramirez H, Vivas J, Castro D, Sanchez V, Andrade O, Buiatti E, Oliver W. Cancer Epidemiol Biomarkers Prev; 1996 Jan; 5(1):41-6. PubMed ID: 8770465 [Abstract] [Full Text] [Related]
12. [Salivary lysozyme in the screening for stomach cancer]. Udut VV, Naumov SA, Karpov AB, Savina EV, Suslova TE. Vopr Onkol; 1992 Jan; 38(2):177-81. PubMed ID: 1300703 [Abstract] [Full Text] [Related]
13. Cancer high-risk subjects identified by serum pepsinogen tests: outcomes after 10-year follow-up in asymptomatic middle-aged males. Yanaoka K, Oka M, Mukoubayashi C, Yoshimura N, Enomoto S, Iguchi M, Magari H, Utsunomiya H, Tamai H, Arii K, Ohata H, Fujishiro M, Takeshita T, Mohara O, Ichinose M. Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):838-45. PubMed ID: 18398025 [Abstract] [Full Text] [Related]
14. Epidemiology of gastric carcinoma: review and future prospects. Correa P, Haenszel W, Tannenbaum S. Natl Cancer Inst Monogr; 1982 Apr; 62():129-34. PubMed ID: 7167174 [Abstract] [Full Text] [Related]
15. Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies. Camorlinga-Ponce M, Flores-Luna L, Lazcano-Ponce E, Herrero R, Bernal-Sahagún F, Abdo-Francis JM, Aguirre-García J, Muñoz N, Torres J. Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2498-504. PubMed ID: 18768521 [Abstract] [Full Text] [Related]
16. [Evaluation of serum pepsinogen I , II and osteopontin co-detection in gastric cancer screening]. Gong YH, Sun LP, Yuan Y. Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):691-3. PubMed ID: 17274377 [Abstract] [Full Text] [Related]
17. Anti-parietal cell antibody and serum pepsinogen assessment in screening for gastric carcinoma. Sugiu K, Kamada T, Ito M, Kaya S, Tanaka A, Kusunoki H, Hata J, Haruma K. Dig Liver Dis; 2006 May; 38(5):303-7. PubMed ID: 16549394 [Abstract] [Full Text] [Related]
18. Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects. Yoshihara M, Sumii K, Haruma K, Kiyohira K, Hattori N, Kitadai Y, Komoto K, Tanaka S, Kajiyama G. Am J Gastroenterol; 1998 Jul; 93(7):1090-6. PubMed ID: 9672336 [Abstract] [Full Text] [Related]
19. The multidisciplinary management of gastrointestinal cancer. Epidemiology of oesophagogastric cancer. Lambert R, Hainaut P. Best Pract Res Clin Gastroenterol; 2007 Jul; 21(6):921-45. PubMed ID: 18070696 [Abstract] [Full Text] [Related]
20. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies. Cao Q, Ran ZH, Xiao SD. J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130 [Abstract] [Full Text] [Related] Page: [Next] [New Search]